Drawing for TRANSFORMING TRANSFUSION MEDICINE

USPTO serial 76233263

TRANSFORMING TRANSFUSION MEDICINE

Reviewed by CopyMark Law Group

Reg. 2806997Status 710
Filing date
Status date
Registration date
Jan 20, 2004
Examiner
SNAPP, TINA LOUISE
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TRANSFORMING TRANSFUSION MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Antoinette G. Giugliano

Antoinette G. Giugliano ANTOINETTE G. GIUGLIANO, PC DBA AGG INTELLECTUAL P100 CUMMINGS CENTERSUITE 227CBEVERLY, MA 01915

Goods and services

ClassDescriptionStatusFirst use
005Clinical medical re-agents for processing human and animal blood and blood components for use in blood transfusions and any extracorporeal blood processing stored in bags, [ bottles, syringes, ] and other such containers used to store such substances in the medical fieldSECTION 8 - CANCELLEDMar 7, 2003
010Medical devices, namely, tubing and valve assembly sets and electromechanical fluid instruments, and other similar or related devices, that process human and animal red blood cells and blood components with clinical medical re-agents for the purpose of converting and chemically modifying blood groups and other blood antigens and actively processing blood and blood components for use in blood transfusions and other uses in the medical, veterinary and research fieldsSECTION 8 - CANCELLEDMar 7, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 2, 2024CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jan 20, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 30, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 6, 2014NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Feb 6, 2014RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Feb 6, 201489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Feb 6, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 17, 201489AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Jan 17, 2014E89RTEAS SECTION 8 & 9 RECEIVED—
Jan 28, 2010ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 18, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 13, 2009C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 11, 2009PLGLASSIGNED TO PARALEGAL—
Feb 9, 2009E815TEAS SECTION 8 & 15 RECEIVED—
Jun 22, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 30, 2004MAILPAPER RECEIVED—
Jan 20, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 19, 2003CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 17, 2003DOCKASSIGNED TO EXAMINER—
Nov 13, 2003CFITCASE FILE IN TICRS—
Nov 5, 2003SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 8, 2003IUAFUSE AMENDMENT FILED—
Oct 8, 2003MAILPAPER RECEIVED—
Apr 14, 2003EX2GSOU EXTENSION 2 GRANTED—
Mar 14, 2003EXT2SOU EXTENSION 2 FILED—
Mar 14, 2003MAILPAPER RECEIVED—
Aug 21, 2002MAILPAPER RECEIVED—
Jun 27, 2002EX1GSOU EXTENSION 1 GRANTED—
Jun 6, 2002EXT1SOU EXTENSION 1 FILED—
May 7, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 12, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 23, 2002NPUBNOTICE OF PUBLICATION—
Nov 5, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 17, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance